201 related articles for article (PubMed ID: 1649252)
1. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.
Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP
J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252
[TBL] [Abstract][Full Text] [Related]
2. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
Zuddas A; Fascetti F; Corsini GU; Piccardi MP
Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
[TBL] [Abstract][Full Text] [Related]
3. Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
Vaglini F; Fascetti F; Tedeschi D; Cavalletti M; Fornai F; Corsini GU
Neurodegeneration; 1996 Jun; 5(2):129-36. PubMed ID: 8819133
[TBL] [Abstract][Full Text] [Related]
4. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury.
Reinhard JF; Miller DB; O'Callaghan JP
Neurosci Lett; 1988 Dec; 95(1-3):246-51. PubMed ID: 3265770
[TBL] [Abstract][Full Text] [Related]
5. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
Moy LY; Albers DS; Sonsalla PK
Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
[TBL] [Abstract][Full Text] [Related]
6. Diethyldithiocarbamate and disulfiram inhibit MPP+ and dopamine uptake by striatal synaptosomes.
Di Monte D; Irwin I; Kupsch A; Cooper S; DeLanney LE; Langston JW
Eur J Pharmacol; 1989 Jul; 166(1):23-9. PubMed ID: 2553428
[TBL] [Abstract][Full Text] [Related]
7. (+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice.
Vaglini F; Fascetti F; Fornai F; Maggio R; Corsini GU
Brain Res; 1994 Dec; 668(1-2):194-203. PubMed ID: 7704605
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
O'Callaghan JP; Miller DB; Reinhard JF
Brain Res; 1990 Jun; 521(1-2):73-80. PubMed ID: 1976416
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.
Gainetdinov RR; Fumagalli F; Jones SR; Caron MG
J Neurochem; 1997 Sep; 69(3):1322-5. PubMed ID: 9282960
[TBL] [Abstract][Full Text] [Related]
10. Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum.
Zuddas A; Corsini GU; Schinelli S; Barker JL; Kopin IJ; di Porzio U
Brain Res; 1989 Oct; 501(1):11-22. PubMed ID: 2804689
[TBL] [Abstract][Full Text] [Related]
11. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
Ookubo M; Yokoyama H; Kato H; Araki T
Mol Cell Endocrinol; 2009 Nov; 311(1-2):62-8. PubMed ID: 19631714
[TBL] [Abstract][Full Text] [Related]
12. The effect of diethyldithiocarbamate on the biodisposition of MPTP: an explanation for enhanced neurotoxicity.
Irwin I; Wu EY; DeLanney LE; Trevor A; Langston JW
Eur J Pharmacol; 1987 Sep; 141(2):209-17. PubMed ID: 2824216
[TBL] [Abstract][Full Text] [Related]
13. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
14. MPP
Cunha MP; Pazini FL; Lieberknecht V; Budni J; Oliveira Á; Rosa JM; Mancini G; Mazzardo L; Colla AR; Leite MC; Santos ARS; Martins DF; de Bem AF; Gonçalves CAS; Farina M; Rodrigues ALS
Mol Neurobiol; 2017 Oct; 54(8):6356-6377. PubMed ID: 27722926
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
Fuller RW; Hemrick-Luecke SK; Robertson DW
Biochem Pharmacol; 1988 Sep; 37(17):3343-7. PubMed ID: 3135812
[TBL] [Abstract][Full Text] [Related]
16. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
Chan P; Langston JW; Di Monte DA
J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
[TBL] [Abstract][Full Text] [Related]
17. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
[TBL] [Abstract][Full Text] [Related]
18. Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.
Götz ME; Dirr A; Burger R; Janetzky B; Weinmüller M; Chan WW; Chen SC; Reichmann H; Rausch WD; Riederer P
Eur J Pharmacol; 1994 Feb; 266(3):291-300. PubMed ID: 8174612
[TBL] [Abstract][Full Text] [Related]
19. Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant.
Reinhard JF; Daniels AJ; Viveros OH
Neurosci Lett; 1988 Aug; 90(3):349-53. PubMed ID: 3262206
[TBL] [Abstract][Full Text] [Related]
20. Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP.
Walters TL; Irwin I; Delfani K; Langston JW; Janson AM
Exp Neurol; 1999 Mar; 156(1):62-70. PubMed ID: 10192777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
